Distribution of genotypes among patients with significant cardiac recovery weaned off MCS (Group II) compared with patients without recovery (Group III)
| . | Group II (n = 20) . | Group III (n = 29) . | P-value . |
|---|---|---|---|
| Allele frequency | |||
| CTGF_c.-945C | 15 | 31 | 0.12 |
| CTGF_c.-945G | 25 | 27 | |
| Dominant model | |||
| C/C | 5 | 7 | 0.95 |
| C/G + G/G | 15 | 22 | |
| Recessive model | |||
| C/C + C/G | 10 | 24 | 0.03 |
| G/G | 10 | 5 | |
| . | Group II (n = 20) . | Group III (n = 29) . | P-value . |
|---|---|---|---|
| Allele frequency | |||
| CTGF_c.-945C | 15 | 31 | 0.12 |
| CTGF_c.-945G | 25 | 27 | |
| Dominant model | |||
| C/C | 5 | 7 | 0.95 |
| C/G + G/G | 15 | 22 | |
| Recessive model | |||
| C/C + C/G | 10 | 24 | 0.03 |
| G/G | 10 | 5 | |
Distribution of genotypes among patients with significant cardiac recovery weaned off MCS (Group II) compared with patients without recovery (Group III)
| . | Group II (n = 20) . | Group III (n = 29) . | P-value . |
|---|---|---|---|
| Allele frequency | |||
| CTGF_c.-945C | 15 | 31 | 0.12 |
| CTGF_c.-945G | 25 | 27 | |
| Dominant model | |||
| C/C | 5 | 7 | 0.95 |
| C/G + G/G | 15 | 22 | |
| Recessive model | |||
| C/C + C/G | 10 | 24 | 0.03 |
| G/G | 10 | 5 | |
| . | Group II (n = 20) . | Group III (n = 29) . | P-value . |
|---|---|---|---|
| Allele frequency | |||
| CTGF_c.-945C | 15 | 31 | 0.12 |
| CTGF_c.-945G | 25 | 27 | |
| Dominant model | |||
| C/C | 5 | 7 | 0.95 |
| C/G + G/G | 15 | 22 | |
| Recessive model | |||
| C/C + C/G | 10 | 24 | 0.03 |
| G/G | 10 | 5 | |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
